Drug intelligence / Profile preview

N-Methylmesoporphyrin containing copper

Development stage
Preclinical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01

Overview

N-Methylmesoporphyrin containing copper is a specific copper metalloporphyrin complex. Its ligand, N-Methylmesoporphyrin IX (NMM), is a non-planar porphyrin derivative recognized for its ability to inhibit ferrochelatase, an enzyme critical for heme biosynthesis. NMM also selectively binds to and stabilizes G-quadruplex DNA structures. The incorporation of copper into the porphyrin ring forms a coordination complex. While NMM itself is primarily utilized as a research probe for G-quadruplex DNA and amyloid-β aggregation, copper porphyrin complexes, including those with nitrile functionalities, have demonstrated anticancer activity. This activity is often mediated through mechanisms such as DNA intercalation and the induction of mitochondrial dysfunction, suggesting potential therapeutic applications for copper-containing N-Methylmesoporphyrin, although its specific development as a therapeutic drug is not widely reported.

Other names
N-METHYLMESOPORPHYRIN CONTAINING COPPER3-(18-(2-Carboxyethyl)-7,12-diethyl-3,8,13,17,23-pentamethylporphyrin-21-id-2-yl)propanoic acid;copper(1+)DB02188DB-02188DB 02188
02

Targets

FECH (Ferrochelatase)G4 (G-quadruplex DNA)DNA

Beyond the preview

Go deeper on N-Methylmesoporphyrin containing copper.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-Methylmesoporphyrin containing copper.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call